Retension Pharmaceuticals (RTSN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $12.21, +4.90% vs the prior close of $11.64.
- Volume 131.00K shares, 0.4x its 50-day average (light).
- New SEC filings: SCHEDULE 13G (Oct 15, 2026), SCHEDULE 13D (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
RTSN jumps 4.9% to $12.21, 4 up days in a row. Closed at $12.21, +4.90% vs the prior close of $11.64. Day range $11.56–$12.86, opened at $11.56.
RTSN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — RTSN jumps 4.9% to $12.21, 4 up days in a row
- Closed at $12.21, +4.90% vs the prior close of $11.64. Day range $11.56–$12.86, opened at $11.56.
- Volume was 131.00K shares, 0.4x its 50-day average of 294.48K — lighter than usual.
- 52-week range $9.66–$12.86; today's close sits at 80% of that range, 5.1% below the 52-week high.
- That makes 4 straight gains.
Oct 14, 2026 — RTSN ends flat (+0.1%) to $11.64, 3 up days in a row
- Closed at $11.64, +0.09% vs the prior close of $11.63. Day range $11.00–$12.25, opened at $11.63.
- Volume was 77.20K shares, 0.2x its 50-day average of 366.90K — lighter than usual.
- 52-week range $9.66–$12.50; today's close sits at 70% of that range, 6.9% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — RTSN rises 2.7% to $11.63
- Closed at $11.63, +2.74% vs the prior close of $11.32. Day range $11.41–$12.50, opened at $11.83.
- Volume was 137.60K shares, 0.3x its 50-day average of 481.55K — lighter than usual.
- 52-week range $9.66–$12.50; today's close sits at 69% of that range, 7.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — RTSN jumps 7.5% to $11.32
- Closed at $11.32, +7.50% vs the prior close of $10.53. Day range $10.16–$11.79, opened at $10.88.
- Volume was 173.90K shares, 0.2x its 50-day average of 789.20K — lighter than usual.
- 52-week range $9.66–$11.79; today's close sits at 78% of that range, 4.0% below the 52-week high.
RTSN latest news & SEC filings
Every SEC filing by or about RTSN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 14, 2026 · SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Keller Eric L. bought 20,800 shares at $12.00 (≈$249.60K) on Oct 13, 2026; now holds 423,377
- Keller Eric L. converted 9,662 shares on Oct 13, 2026; now holds 433,039
- Keller Eric L. converted 31,368 shares on Oct 13, 2026; now holds 464,407
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sweetnam Paul converted 4,026 shares on Oct 13, 2026; now holds 406,603
- Sweetnam Paul converted 2,640 shares on Oct 13, 2026; now holds 2,640
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Olds Donald converted 5,637 shares on Oct 13, 2026; now holds 5,637
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bisson Sabine converted 1,611 shares on Oct 13, 2026; now holds 1,611
- Bisson Sabine converted 2,504 shares on Oct 13, 2026; now holds 4,115
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Berger Franklin M converted 12,517 shares on Oct 13, 2026; now holds 12,517
- Berger Franklin M bought 10,000 shares at $12.00 (≈$120.00K) on Oct 13, 2026; now holds 10,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Oct 9, 2026 · 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade RTSN
- How much it moves: over the last 20 sessions the average daily move was 3.81% (largest 7.5%). That is a volatile stock.
- Liquidity: about 261.78K shares (≈$3.20M) trade per day on average.
- 52-week position: $12.21 vs a range of $9.66–$12.86 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RTSN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 11.56 | 12.86 | 11.56 | 12.21 | 131.00K |
| Oct 14, 2026 | 11.63 | 12.25 | 11.00 | 11.64 | 77.20K |
| Oct 13, 2026 | 11.83 | 12.50 | 11.41 | 11.63 | 137.60K |
| Oct 12, 2026 | 10.88 | 11.79 | 10.16 | 11.32 | 173.90K |
| Oct 9, 2026 | 10.00 | 11.60 | 9.66 | 10.53 | 789.20K |
About Retension Pharmaceuticals
Retension Pharmaceuticals (RTSN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MCLEAN, VA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2002988.
RTSN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RTSN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
RTSN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on RTSN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.